Stellate Communications

Not every website starts from the same place... & not every budget does either ✨ We offer 3 web packages built for different stages, timelines & goals. Fully bespoke custom builds, to a launched site in a month — see how they compare 👇🏽 Get a quote: stellatecomms.com/creative

Feeling a bit verklempt to be honored with the 2026 Breslau/Murphy Award from @APPAassociation. It’s hard to overstate how much an award like this means to me. I love science, and training the next generation of scientists isn’t part of the job, it IS the job.

Thanks to @OneMindOrg for consistently championing the importance of community. Whether in the lab or through the arts, the power of connection is vital to transforming mental health care.

We’re excited to welcome Maria Kalambokidis, PhD, to Stellate as an Account Coordinator ✨ Maria is an evolutionary biologist with expertise in academic research, STEM engagement, and science writing. We’re thrilled to have her on the team 💜 Learn more: stellatecomms.com/team

Neurotechnology is bottlenecked by systems, not science. Cochlear implants, deep brain stimulation, and neurostimulators have restored function for hundreds of thousands of patients and have collectively generated billions in annual reimbursements. PL Neuro is sharing a roadmap series focused on answering the question: where does coordination compress timelines the most? The first roadmap describes how the neurotech field can get to $100B+ — and faster. The question isn’t if neurotech will change the future of human health, it’s how quickly. So far, the biggest constraint isn’t FDA approval, it’s what comes after: there’s a multi-year gap between “safe & effective” (FDA) and “paid for” (CMS). This commercial valley of death delays: -Patient access -Company survival -Capital formation -Field-wide progress If we fix time-to-revenue, we can unlock: -Institutional capital at scale -Faster clinical adoption -The path to consumer neurotech Clinical revenue is the acceleration layer. This roadmap proposes a different approach: Not company-by-company progress, but coordinated, ecosystem-level infrastructure. 1. Close the FDA–CMS gap (<12 months) 2. Build shared CPT code frameworks 3. Create an “orphan implant” backstop 4. Align policy, capital, and clinical incentives Neurotech is entering a platform era. The devices are no longer static, they are adaptive, software-defined systems. Our regulatory and reimbursement systems need to catch up. The next decade won’t be won by individual companies. It will be won by an ecosystem that moves fast together.

What an incredible evening 🎶 Thank you, @onemindorg, for a meaningful night about music and mental health. Music is such a powerful tool for healing!

SAVE THE DATE! Join Dr. Yasmin Hurd (@neurovoice) for the Addiction Institute of Mount Sinai's annual Dr. Robert Newman Lecture! Keynote Speaker: Dr. @Lorenzo__Leggio Panel discussion: Drs. Pamela Mund, Frances Lee, @PaulKennyPhD & @MAparvaz RSVP👉docs.google.com/forms/d/e/1FAI…

"I had a wonderful time working with Stellate building my new lab website... I would highly recommend them to anyone looking for a creative, responsive, and professional team." Thanks for the kind words @cglowther, and congrats on launch!🧬 See it here: thelowtherlab.com

PL Neuro is officially live! plneuro.xyz We exist to break bottlenecks, accelerate progress in neurotech & NeuroAI, and to invest in innovations that benefit humanity. This project of @protocollabs will focus on: 1. Neural augmentation 2. Biologically-inspired intelligence 3. Whole brain emulation

Our paper is now published in @NatMentHealth. What began as curiosity in med school became a field I later named: metabolic psychiatry. 15+ years later, it's defining a new category of care. @LabsMetabolism is translating this into patient care. nature.com/articles/s4422…

Congratulations to Dr. Sarah Stern a new Associate Member of ACNP! Welcome!! 👏

The requested boost would help counter the planned sunsetting of one of the program’s long-standing funding streams, which will result in a $195 million drop in funding for fiscal year 2027. By @avaskham thetransmitter.org/funding/letter…

Excited to have @yusterafa as our third #OptoGRC2026 keynote speaker! Join us for his talk on how neural circuits & dendritic spines work together to "orchestrate" brain activity 🎹✨ Don’t miss the chance to attend — registration closes 4/12. grc.org/optogenetic-ap…

Neurotechnology is one of the defining opportunities of this century. We’re already seeing the potential to restore function, treat disease, and eventually expand human capability. It’s no longer speculative. Now, the question is how fast can it translate into real products, real companies, and real patient impact. PL Neuro is sharing a roadmap series for that future. Safe, high-fidelity neural interfaces have been substantially de-risked. So the bottleneck is shifting from science to systems. What’s slowing the field now? - regulatory lag - reimbursement gaps - capital constraints - public trust In other words: structural friction. Today, each company is forced to navigate these barriers alone. Neurotech needs shared infrastructure: a Neurotech Commons. This roadmap series is a strategic briefing focused on one question: Where does coordination compress timelines the most? Four core bottlenecks: 1. Path to clinical revenue 2. Transition to consumer 3. Public narrative & trust 4. Capital formation Taken together, these roadmaps make one argument: the arrival of neurotechnology is inevitable. But the timeline is not and timelines matter for patients, for science, for society. This series is a starting point for deeper collaboration across the field. If you’re building, researching, investing in, or shaping neurotechnology policy, please share your feedback.

When I started @stellatecomms, I was so excited about the new science I would learn... 🪲 Ticks weren't on my list, but they've been a recent highlight! Check out the Tick Global Network: tickgn.org

We have fixed a major inference bug in bioreason.net, significantly improving the quality of reasoning Give BioReason-Pro another try! And please keep the feedback coming You can also find a guide on setting up the model locally at bioreason.net/code

Scientists and educators are concerned about students using AI to shortcut their learning. But there are also opportunities, especially when it comes to teaching neuroscience students how to code, writes @analog_ashley. thetransmitter.org/how-to-teach-t…

At Stellate, we recognize #SciComm must happen at every level, and sometimes, it goes deeper than the message itself. Our own @BaileyCSarka at #SciTalk26 will share real-world insights on building communication bridges to reach rural populations. Stop by her talk! 👇

Congrats to @faunarobotics on their acquisition by Amazon! Proud to have been a part of the early founding team 🤖🌱abcnews.com/Business/wireS…

It kind of feels like magic 🪄🐰🎩

You've been meaning to break ground on your website for months... or longer... ✨ Site Lab exists for exactly this ✨ Hand us content + a few aesthetic preferences, and we build it — color palette, fonts, layout, mobile optimization —& then launch it🚀 stellatecomms.com/creative